Astra Zeneca signs deal with Europe's Inclusive Vaccines Alliance for coronavirus vaccine supply

The agreement will supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, following approval, across the European Union. Oxford University has recently begun testing AZD1222 in a Phase II/III UK trial involving around 10,000 adult volunteers.